Home>Topics>Companies>AstraZeneca

AstraZeneca

  1. All
  2. Commentary
  3. Video Reports
  4. Headlines
  1. AstraZeneca CEO says new Pfizer bid unlikely-Swedish daily DI

    Headlines

    Sat, 20 Dec 2014

    STOCKHOLM, Dec 20 (Reuters) - U.S. Pfizer is unlikely to come back with a fresh bid for AstraZeneca , the Anglo-Swedish pharmaceuticals group's top executive was quoted as saying by Swedish business...

  2. UPDATE 1- AstraZeneca's ovarian cancer drug gets U.S. approval

    Headlines

    Fri, 19 Dec 2014

    Dec 19 (Reuters) - AstraZeneca Plc 's ovarian cancer drug has been granted an accelerated approval by the U.S. health regulator, a day after the treatment was approved by the European Commission.

  3. FDA grants accelerated approval to AstraZeneca's ovary cancer drug

    Headlines

    Fri, 19 Dec 2014

    Dec 19 (Reuters) - AstraZeneca Plc 's ovarian cancer drug has been granted an accelerated approval by the U.S. health regulator, a day after it was approved by the European Commission.

  4. AstraZeneca first-in-class ovarian cancer drug wins EU approval

    Headlines

    Thu, 18 Dec 2014

    LONDON, Dec 18 (Reuters) - AstraZeneca 's all-important cancer drug business received a fillip on Thursday as a new medicine against ovarian cancer was approved in Europe, making it the first of its...

  5. BRIEF- Astrazeneca's Lynparza gets EU approval

    Headlines

    Thu, 18 Dec 2014

    * Lynparza approved in European Union as first-in-class treatment for advanced BRCA-mutated ovarian cancer Source text for Eikon: Further company coverage:

  6. United States Anesthesia Drugs Market & Forecast

    Commentary

    Fri, 12 Dec 2014

    Profile in United States Anesthetic Drugs Market Baxter International Inc Endo Health Solutions Inc Abbott Laboratories AstraZeneca Data Sources This report is built using data and information sourced from proprietary databases, primary and secondary

  7. AstraZeneca , Nektar constipation drug wins European approval

    Headlines

    Tue, 9 Dec 2014

    LONDON, Dec 9 (Reuters) - AstraZeneca 's new drug for the treatment of opioid-induced constipation, which was developed with Nektar Therapeutics, has been approved in the European Union, the British company said on Tuesday.

  8. BRIEF- Astrazeneca's Moventig treatment approved in the EU

    Headlines

    Tue, 9 Dec 2014

    * Moventig  approved in european union for opioid-induced constipation Source text for Eikon: Further company coverage:

  9. AstraZeneca , Ranbaxy prevail in Nexium antitrust trial

    Headlines

    Fri, 5 Dec 2014

    Dec 5 (Reuters) - A Massachusetts jury has found that an agreement between AstraZeneca Plc and Ranbaxy Laboratories Ltd to delay the launch of a generic version of AstraZeneca 's heartburn drug Nexium...

  10. Astra says U.S. Nexium antitrust case returns favourable ruling

    Headlines

    Fri, 5 Dec 2014

    LONDON, Dec 5 (Reuters) - AstraZeneca said a jury in the U.S. ruled in its favour in an antitrust litigation over heartburn drug Nexium, a case brought against it by various buying groups who challenged a previous settlement.

« Prev12345Next »
Content Partners